Salmeterol
- Generic Name
- Salmeterol
- Brand Names
- Advair, Airduo, Airduo Respiclick, Serevent, Serevent Diskus, Wixela
- Drug Type
- Small Molecule
- Chemical Formula
- C25H37NO4
- CAS Number
- 89365-50-4
- Unique Ingredient Identifier
- 2I4BC502BT
- Background
Salmeterol is a long-acting beta-2 adrenergic receptor agonist drug that is currently prescribed for the treatment of asthma and chronic obstructive pulmonary disease COPD. It has a longer duration of action than the short-acting beta-2 adrenergic receptor agonist, salbutamol. Salmeterol was first described in the literature in 1988. Salmeterol's structure i...
- Indication
用于哮喘（包括夜间哮喘和运动性哮喘）、喘息性支气管炎和可逆性气道阻塞。
- Associated Conditions
- Asthma, Chronic Obstructive Pulmonary Disease (COPD), Exercise-Induced Bronchospasm
- Associated Therapies
- -
Efficacy of Inhaling Bronchodilator Medications in Chronic Obstructive Pulmonary Disease
- Conditions
- Interventions
- First Posted Date
- 2011-07-12
- Last Posted Date
- 2013-08-07
- Lead Sponsor
- Dartmouth-Hitchcock Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT01391559
- Locations
- 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
Fluticasone and Salmeterol in Allergic Rhinitis
- Conditions
- Interventions
- First Posted Date
- 2011-07-06
- Last Posted Date
- 2019-10-16
- Lead Sponsor
- University of Dundee
- Target Recruit Count
- 23
- Registration Number
- NCT01388595
- Locations
- 🇬🇧
Asthma and Allergy Research Group, University of Dundee, Dundee, United Kingdom
Sunovion Brovana Versus Serevent Inspiratory Capacity High Resolution Computed Tomography
- Conditions
- Interventions
- First Posted Date
- 2011-05-27
- Last Posted Date
- 2012-07-20
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 20
- Registration Number
- NCT01361984
- Locations
- 🇺🇸
UCLA, Los Angeles, California, United States
Effects of Anticholinergic or Long-Acting Beta 2 Agonist on FeNO and Pulmonary Function in SCI
- First Posted Date
- 2011-05-19
- Last Posted Date
- 2015-10-23
- Lead Sponsor
- James J. Peters Veterans Affairs Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT01355991
- Locations
- 🇺🇸
Kessler Institute for Rehabilitation, West Orange, New Jersey, United States
🇺🇸James J. Peters VA Medical Center, Bronx, New York, United States
A 4-week Dose-Ranging, Dose-Interval, Efficacy, Safety and Tolerability Study of GSK961081 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
- Conditions
- Interventions
- First Posted Date
- 2011-03-21
- Last Posted Date
- 2016-12-01
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 437
- Registration Number
- NCT01319019
- Locations
- 🇺🇦
GSK Investigational Site, Vinnytsia, Ukraine
Blacks and Exacerbations on Long Acting Beta Agonists (LABA) vs. Tiotropium (BELT)
- First Posted Date
- 2011-02-07
- Last Posted Date
- 2018-03-30
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 1070
- Registration Number
- NCT01290874
- Locations
- 🇺🇸
G.A. Carmichael F.H.C., Canton, Mississippi, United States
🇺🇸Edward Waters College Medical Center (Mayo), Jacksonville, Florida, United States
🇺🇸Northwestern University, Chicago, Illinois, United States
Effect of Salmeterol on Fluid Clearance From Alveolar-Capillary Membrane in COPD Patients
- Conditions
- Interventions
- First Posted Date
- 2011-01-06
- Last Posted Date
- 2011-01-06
- Lead Sponsor
- University of Milan
- Target Recruit Count
- 20
- Registration Number
- NCT01271556
- Locations
- 🇮🇹
Respiratory Medicine Section, Dipartimento Toraco-Polmonare e Cardiocircolatorio, Università degli Studi di Milano, San Paolo Hospital, Milan, Italy
Interactive Acute Smooth Muscle Effects of Salmeterol and Fluticasone in the Airway
- Conditions
- Interventions
- First Posted Date
- 2010-11-01
- Last Posted Date
- 2016-06-30
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 14
- Registration Number
- NCT01231230
Effects of Inhaled Corticosteroids on Sputum Bacterial Load in COPD
- Conditions
- Interventions
- First Posted Date
- 2010-10-04
- Last Posted Date
- 2016-04-08
- Lead Sponsor
- Università degli Studi di Ferrara
- Target Recruit Count
- 60
- Registration Number
- NCT01213693
- Locations
- 🇮🇹
Research Centre on Asthma and COPD - Department of Clinical and Experimental Medicine - Section of Respiratory Disease - University of Ferrara, Ferrara, Italy
Efficacy and Safety of Different Doses of Indacaterol
- Conditions
- Interventions
- First Posted Date
- 2010-03-02
- Last Posted Date
- 2011-08-19
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 511
- Registration Number
- NCT01079130
- Locations
- 🇺🇸
Novartis Investigative site, North Charleston, South Carolina, United States
🇺🇸Novartis Investigator Site, Seattle, Washington, United States
🇺🇸Novartis Investigative Site, Charleston, South Carolina, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.